<DOC>
	<DOCNO>NCT01161355</DOCNO>
	<brief_summary>The primary objective study ass absolute bioavailability evaluate pharmacokinetic parameter single oral dose radiolabelled intravenous microdose [ 14C ] AZD9668 healthy male subject .</brief_summary>
	<brief_title>Phase I , Exploratory , Single Centre , Single Oral Dose AZD9668 Intravenous Microdose C14 AZD9668 , Healthy Subject</brief_title>
	<detailed_description>This exploratory study ass absolute bioavailability single oral dose AZD9668 respect intra-venous microdose [ 14C ] AZD9668 healthy male subject .</detailed_description>
	<criteria>Provision sign date , write informed consent prior study specific procedure Have body mass index ( BMI ) 18 30 kg/m2 inclusive weight least 50 kg 100 kg . Any clinically significant disease disorder Any clinically significant abnormality screen examination</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>healthy</keyword>
	<keyword>microdose</keyword>
</DOC>